Leading medical technology firm expands office space requirement

Phagenesis takes on additional space at Manchester Science Park

Article posted: 01 Sep 2011

Existing office space tenant at Manchester Science Parks, Phagenesis, a leader in technology for the treatment of stroke patients, has taken on larger office space at msp’s Corridor site due to rapid growth and increased staff numbers.

The company, which was spun out from the University of Manchester, has attracted funding from a number of experienced investors, most recently raising £2m towards the development of a device that delivers electrical pulses to the throat that can “awaken” the brain to help restore swallowing function in stroke victims.

As a result, the business has grown from two to six staff members and moved from a small office in msp’s MedTECH Centre to a 1,428 sq ft office in Enterprise House. The company plans to grow the team by at least two more by the end of 2011.

Daniel Green, CEO at Phagenesis said: “Our rapid growth and continued support from investors is testament to the quality of the research behind this device and the high calibre team we have in place.”

“Being unable to swallow safely is a life-threatening condition. Our technology is the first to have been proven to work in well-controlled clinical trials, and we are now planning product launches.”

Dysphagic patients cannot swallow normally. Dysphagia can be mild or severe, and is most commonly caused by stroke and brain injury where the part of the brain responsible for swallowing has been damaged. Other causes include diseases like multiple sclerosis, Parkinson’s, Alzheimer’s and motor neurone disease.

For breaking news relating to office space in the North West follow us on http://twitter.com/officespacenews

Posted by Sam